The Influence of the Thickening of Bowman's Capsule on the Clinical Prognosis of Patients With Diabetic Kidney Disease
Status
Conditions
Treatments
Details and patient eligibility
About
Diabetic kidney disease (DKD) is the leading cause for renal replacement therapy in developed country. DKD is also the primary cause of ESKD among middle-aged and elderly people in China. Renal pathological markers have been proved to have clinical and prognostic value in both non diabetic and diabetic kidney diseases. To discriminate lesions by various degrees of severity, the Working Group of the Renal Pathology Society (RPS) developed a pathologic classification for DKD in 2010. The classification is based on glomerular lesions, with a separate evaluation for interstitial and vascular lesions. In a decade, there were several new characteristics common to DKD, such as the presence of mesangiolysis, glomerular hyalinosis, segmental sclerosis and extracapillary hypercellularity, which have been noted in patients with diabetes and may have prognostic importance. But it is still unclear whether thickening of Bowman's capsule predicts the progression of DKD.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
-
- Age ≥ 18 years old, male or female 2) Patients diagnosed as diabetes kidney disease by renal biopsy
Exclusion criteria
-
- Patients combined with non diabetes kidney disease; 2) Patients with kidney transplant failure; 3) Patients undergoing zero point puncture for kidney transplantation; 4) less than 5 glomeruli in the renal puncture sample.
Trial design
250 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Jiayue Lu
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal